• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8 filed

    12/23/20 11:34:31 AM ET
    $RELV
    Major Pharmaceuticals
    Health Care
    Get the next $RELV alert in real time by email
    EDGAR Filing Documents for 0001437749-20-025842
    Home | Latest Filings | Previous Page
    SEC Seal
    SEC Banner
    Search the Next-Generation EDGAR System
    Filing Detail
    • SEC Home »
    • Search the Next-Generation EDGAR System »
    • Company Search »
    • Current Page
    Form 8-K - Current report:
    SEC Accession No. 0001437749-20-025842
    Filing Date
    2020-12-23
    Accepted
    2020-12-23 11:34:31
    Documents
    1
    Period of Report
    2020-12-21
    Items
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    Document Format Files

    Seq Description Document Type Size
    1 FORM 8-K relv20201223_8k.htm 8-K 21839
      Complete submission text file 0001437749-20-025842.txt   23127
    Mailing Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405
    Business Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405 636-537-9715
    RELIV INTERNATIONAL INC (Filer) CIK: 0000768710 (see all company filings)

    IRS No.: 371172197 | State of Incorp.: DE | Fiscal Year End: 1231
    Type: 8-K | Act: 34 | File No.: 000-19932 | Film No.: 201410716
    SIC: 2834 Pharmaceutical Preparations
    Office of Life Sciences

    Get the next $RELV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RELV

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RELV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Reliv International, Inc. Announces Update to its Reverse Stock Split Transaction and Plan to Delist from NASDAQ and Deregister its Common Stock

    CHESTERFIELD, Mo., Dec. 4, 2020 /PRNewswire/ -- Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements that promote optimal health, today announced an update to its plan to suspend its obligations to file periodic and current reports and other information with the U.S. Securities and Exchange Commission (the "Commission") under the Securities Exchange Act of 1934, as amended (the "Exchange Act") and to delist its common stock from trading on the NASDAQ Stock Exchange as previously announced in a press release on October 19, 2020. December 21, 2020 will be the effective date of the Company's 1-for-2,000 reverse stock split (the "Reverse Split") of its

    12/4/20 4:15:00 PM ET
    $RELV
    Major Pharmaceuticals
    Health Care

    $RELV
    SEC Filings

    View All

    SEC Form 15-12G filed

    15-12G - RELIV INTERNATIONAL INC (0000768710) (Filer)

    1/19/21 9:42:44 AM ET
    $RELV
    Major Pharmaceuticals
    Health Care

    SEC Form SC 13E3/A filed

    SC 13E3/A - RELIV INTERNATIONAL INC (0000768710) (Subject)

    1/19/21 9:32:57 AM ET
    $RELV
    Major Pharmaceuticals
    Health Care

    SEC Form 8 filed

    8-K - RELIV INTERNATIONAL INC (0000768710) (Filer)

    12/23/20 11:34:31 AM ET
    $RELV
    Major Pharmaceuticals
    Health Care